With locations in Europe and Japan, Astrasana Holding remains competitive, agile and flexible. Our international network serves all market segments of the industry.
Switzerland
Astrasana Holding AG
Parent holding company and strategic management of all subsidiaries across five jurisdictions.
Bogen Pharma AG
Swissmedic-licensed pharmaceutical company for the import and distribution of medical cannabis products in Switzerland.
Astrasana Pharma AG
Swissmedic-licensed company for the cultivation of THC-containing medical cannabis flowers in Switzerland.
Astrasana Research AG
Conducts a pilot project with ZHAW University for the regulated dispensing of recreational cannabis in Graubünden.
Astrasana Animal Health AG
Develops and distributes one of the first approved veterinary cannabis products in Europe.
Czech Republic
Astrasana Czech s.r.o.
B2B trade and distribution of THC-free cannabis products to over 18 European countries.
Astrasana Pharma s.r.o.
SUKL-licensed pharmaceutical company for the import and distribution of medical cannabis products in the Czech Republic.
Releaf s.r.o.
Specialized pet nutrition brand developing CBD-based health products for cats and dogs.
Japan
Astrasana Japan
Exclusive distribution of THC-free cannabis products in partnership with GSI CREOS Corp. in Japan.
United Kingdom
Astrasana UK Ltd.
B2B trade and distribution of THC-free cannabis products in the United Kingdom.
Belgium
NexGen DLH
Strategic equity participation with purchase agreement covering 70% market share in the Benelux region.
Astrasana Holding AG
The Astrasana Group is globally active and currently has eight international subsidiaries.
In each country in which we are present, we have established both a specialized company for the distribution of pharmaceutical products and a separate company for the trade in raw materials for the food and cosmetics industry.
In addition, with Astrasana Animal Health AG, we are the first European company to distribute approved CBD veterinary products.
Our group brings together experts and innovators to research and implement breakthrough solutions for the future.
Switzerland
Astrasana Holding AG
Parent holding company and strategic management of all subsidiaries across five jurisdictions.
Bogen Pharma AG
Swissmedic-licensed pharmaceutical company for the import and distribution of medical cannabis products in Switzerland.
Astrasana Pharma AG
Swissmedic-licensed company for the cultivation of THC-containing medical cannabis flowers in Switzerland.
Astrasana Research AG
Conducts a pilot project with ZHAW University for the regulated dispensing of recreational cannabis in Graubünden.
Astrasana Animal Health AG
Develops and distributes one of the first approved veterinary cannabis products in Europe.
Czech Republic
Astrasana Czech s.r.o.
B2B trade and distribution of THC-free cannabis products to over 18 European countries.
Astrasana Pharma s.r.o.
SUKL-licensed pharmaceutical company for the import and distribution of medical cannabis products in the Czech Republic.
Releaf s.r.o.
Specialized pet nutrition brand developing CBD-based health products for cats and dogs.
Japan
Astrasana Japan
Exclusive distribution of THC-free cannabis products in partnership with GSI CREOS Corp. in Japan.
United Kingdom
Astrasana UK Ltd.
B2B trade and distribution of THC-free cannabis products in the United Kingdom.
Belgium
NexGen DLH
Strategic equity participation with purchase agreement covering 70% market share in the Benelux region.